SFX by Ex Libris Inc.

Title:	Specific and nonspecific NK cell activation during virus infection
Source:	Nature Immunology [1529-2908] Dokun, Ayotunde yr:2001

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Carrington, M. "Antiviral synergism." Nature genetics 37.6 (2005): 565-6.
description	2.	Zafirova, B. "Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice." Immunity 31.2 (2009): 270-282.
description	3.	Matsui, M. "T-bet is required for protection against vaccinia virus infection." Journal of virology 79.20 (2005): 12798-806.
description	4.	Nguyen, K.B. B. "Coordinated and distinct roles for IFN-αβ, IL-12, and IL-15 regulation of NK cell responses to viral infection." The journal of immunology 169.8 (2002): 4279-4287.
description	5.	van Bockel, V. "Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation." Annals of vascular surgery 22.4 (2008): 582-97.
description	6.	van, Melany C. "Insights into mechanisms behind arteriogenesis: what does the future hold?" Journal of leukocyte biology 84.6 (2008): 1379-1391.
description	7.	Madeddu, P. "Murine models of myocardial and limb ischemia: Diagnostic end-points and relevance to clinical problems." Vascular pharmacology 45.5 (2006): 281-301.
description	8.	Munks, Michael W W. "Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection." The journal of immunology 178.11 (2007): 7235-41.
description	9.	Massagué, J. "The logic of TGFbeta signaling." FEBS letters 580.12 (2006): 2811-20.
description	10.	Tarrio, Margarite L. "Proliferation conditions promote intrinsic changes in NK cells for an IL-10 response." The journal of immunology 193.1 (2014): 354-63.
description	11.	Patera, Andriani C. "Interleukin 17 modulates the immune response to vaccinia virus infection." Virology 299.1 (2002): 56-63.
description	12.	Cooper, Wayne A. "Memory-like responses of natural killer cells." Immunological reviews 235.1 (2010): 297-305.
description	13.	Amir, J. "Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir." European Journal of Pediatrics 169.9 (2010): 1061-1067.
description	14.	Gresser, I. "Enhanced NK cell activity in mice injected with interferon and interferon inducers." Nature 273.5665 (1978): 759-61.
description	15.	Yokoyama, A A A. "Cmv1 and natural killer cell responses to murine cytomegalovirus infection." Current topics in microbiology and immunology 321 (2008): 101-22.
description	16.	Brey, Eric M M. "Therapeutic neovascularization: contributions from bioengineering." Tissue engineering 11.3-4 (2005): 567-84.
description	17.	Carmeliet, P. "Mechanisms of angiogenesis and arteriogenesis." Nature medicine 6.4 (2000): 389-395.
description	18.	Kisseleva, T. "Signaling through the JAK/STAT pathway, recent advances and future challenges." Gene 285.1-2: 1-24.
description	19.	Massagué, J. "Smad transcription factors." Genes & development 19.23 (2005): 2783-810.
description	20.	Alborno, A. "Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up." Journal of laryngology & otology 123.4 (2008): 1-6.